Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DABIGATRAN vs DABRAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DABIGATRAN vs DABRAFENIB: Safety Overview

Metric DABIGATRAN DABRAFENIB
Total FAERS Reports 2,080 19,305
Deaths Reported 251 4,165
Death Rate 12.1% 21.6%
Hospitalizations 1,309 5,325
Average Patient Age 71.7 yrs 58.3 yrs
% Female Patients 36.3% 48.0%
FDA Approval Date N/A Mar 16, 2023
Manufacturer N/A Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status N/A Prescription